| Literature DB >> 34306076 |
Abstract
OBJECTIVE: To compare the Clavien-Dindo grade and risk factors of complications after dual-port laparoscopic distal gastrectomy (DPLDG) and hand-assisted laparoscopic gastrectomy (HALG).Entities:
Year: 2021 PMID: 34306076 PMCID: PMC8285165 DOI: 10.1155/2021/4747843
Source DB: PubMed Journal: J Oncol ISSN: 1687-8450 Impact factor: 4.375
Comparison of patients' baseline information between the two groups.
| Item | DPLDG group ( | HALG group ( |
|
|
|---|---|---|---|---|
| Gender | 0.101 | 0.750 | ||
| Male | 201 (52.07%) | 207 (53.21%) | ||
| Female | 185 (47.93%) | 182 (46.79%) | ||
|
| ||||
| Mean age ( | 58.47 ± 5.71 | 58.52 ± 5.28 | 0.127 | 0.899 |
| BMI (kg/m2) | 22.41 ± 1.62 | 22.43 ± 1.57 | 0.175 | 0.862 |
| Tumor length (cm) | 4.24 ± 1.03 | 4.29 ± 1.05 | 0.669 | 0.504 |
|
| ||||
| Pathological type | ||||
| Glandular carcinoma | 214 (55.44%) | 219 (56.30%) | 0.058 | 0.810 |
| Squamous cell carcinoma | 114 (29.53%) | 118 (30.33%) | 0.059 | 0.808 |
| Signet-ring cell carcinoma | 58 (15.03%) | 52 (13.37%) | 0.438 | 0.508 |
|
| ||||
| Basic disease | ||||
| Diabetes | 118 (30.57%) | 120 (30.85%) | 0.024 | 0.876 |
| Hypertension | 147 (38.08%) | 153 (39.33%) | 0.127 | 0.721 |
| Kidney disease | 121 (31.35%) | 116 (29.82%) | 0.213 | 0.645 |
|
| ||||
| Tumor location | ||||
| Antrum | 207 (53.63%) | 211 (54.24%) | 0.030 | 0.864 |
| Stomach body | 146 (37.82%) | 151 (38.82%) | 0.081 | 0.776 |
| Gastric angle | 33 (8.55%) | 27 (6.94%) | 0.702 | 0.402 |
|
| ||||
| Range of gastrectomy | 0.104 | 0.747 | ||
| Total gastrectomy | 195 (50.52%) | 192 (49.36%) | ||
| Partial gastrectomy | 191 (49.48%) | 197 (50.64%) | ||
|
| ||||
| TNM stage | ||||
| I | 198 (51.30%) | 201 (51.67%) | 0.011 | 0.917 |
| II | 146 (37.82%) | 149 (38.30%) | 0.019 | 0.891 |
| III | 42 (10.88%) | 39 (10.03%) | 0.151 | 0.697 |
|
| ||||
| Differentiation type | ||||
| Low | 189 (48.96%) | 192 (49.36%) | 0.012 | 0.913 |
| Medium | 152 (39.38%) | 149 (38.30%) | 0.094 | 0.759 |
| High | 45 (11.66%) | 48 (12.34%) | 0.085 | 0.770 |
| Lymphatic metastasis rate (%) | 46.11% (178/386) | 46.53% (181/389) | 0.014 | 0.908 |
|
| ||||
| Infiltrative depth | ||||
| T1 | 134 (34.72%) | 129 (33.16%) | 0.208 | 0.648 |
| T2 | 95 (24.61%) | 93 (23.91%) | 0.052 | 0.819 |
| T3 | 121 (31.35%) | 126 (32.39%) | 0.097 | 0.755 |
| T4a | 36 (9.33%) | 41 (10.54%) | 0.319 | 0.572 |
| Number of lymph nodes submitted for inspection | 24.41 ± 6.46 | 24.46 ± 6.48 | 0.108 | 0.914 |
Comparison of patients' clinical effect indexes between the two groups .
| Indicator | DPLDG group ( | HALG group ( |
|
|
|---|---|---|---|---|
| Surgical time (min) | 173.25 ± 19.73 | 194.36 ± 23.65 | 13.497 | ≤0.001 |
| Intraoperative blood loss (mL) | 162.46 ± 25.36 | 171.35 ± 23.41 | 5.071 | ≤0.001 |
| Incision length (cm) | 5.73 ± 0.58 | 5.81 ± 0.62 | 1.854 | 0.064 |
| Postoperative exhaust time (d) | 2.67 ± 0.59 | 2.53 ± 0.62 | 3.220 | 0.001 |
| Time to return to full-liquid diet for the first time after surgery (d) | 2.36 ± 0.36 | 2.41 ± 0.43 | 1.754 | 0.080 |
| Hospital stay after surgery (d) | 9.35 ± .86 | 9.42 ± 1.73 | 0.543 | 0.588 |
| Off-bed ambulation time after surgery (d) | 2.74 ± 0.61 | 2.68 ± 0.58 | 1.403 | 0.161 |
| Number of lymph nodes being dissected ( | 28.43 ± 3.27 | 28.51 ± 3.16 | 0.346 | 0.729 |
| Time of removing the abdominal drainage tube (h) | 4.15 ± 1.42 | 4.23 ± 1.38 | 0.795 | 0.427 |
|
| ||||
| NRS score (points) | ||||
| 6 h after surgery | 4.72 ± 0.82 | 4.68 ± 1.03 | 0.598 | 0.550 |
| 12 h after surgery | 3.54 ± 0.75 | 3.62 ± 0.68 | 1.556 | 0.120 |
| 24 h after surgery | 2.21 ± 0.53 | 2.28 ± 0.58 | 1.753 | 0.080 |
| 2 d after surgery | 1.47 ± 0.45 | 1.51 ± 0.35 | 1.382 | 0.167 |
|
| ||||
| Aesthetic scoring (cases) | ||||
| Low | 236 (61.14%) | 241 (61.95%) | 0.054 | 0.816 |
| Medium | 85 (22.02%) | 87 (22.37%) | 0.013 | 0.908 |
| High | 65 (16.84%) | 61 (15.68%) | 0.191 | 0.662 |
Comparison of patients' Clavien–Dindo grades of postoperative complications between the two groups [n (%)].
| Complication type | DPLDG group ( | HALG group ( |
|
|
|---|---|---|---|---|
| ≤II | 27 (36.00%) | 53 (51.46%) | 4.190 | 0.041 |
| IIIa | 15 (20.00%) | 18 (17.48%) | 0.183 | 0.669 |
| IIIb | 16 (21.33%) | 12 (11.65%) | 3.524 | 0.060 |
| IVa | 11 (14.67%) | 10 (9.71%) | 1.025 | 0.311 |
| IVb | 4 (5.33%) | 7 (6.80%) | 0.160 | 0.689 |
| V | 2 (2.67%) | 3 (2.91%) | 0.010 | 0.922 |
| Overall complication incidence | 75 (19.43%) | 103 (26.48%) | 5.440 | 0.020 |
Single-factor and multivariate analysis of risk factors of postoperative complications in patients of both groups.
| Item | Single-factor analysis | Multivariate analysis | ||
|---|---|---|---|---|
| Overall incidence rate of complications (%) |
| OR value (95% CI) |
| |
| Gender | 0.426 | |||
| Male | 12.10 | |||
| Female | 10.84 | |||
|
| ||||
| Age | 0.007 | 1 | 0.037 | |
| <60 years old | 9.29 | 1.346 (1.048, 1.761) | ||
| ≥60 years old | 13.68 | |||
|
| ||||
| Range of gastrectomy | 0.339 | |||
| Total gastrectomy | 12.26 | |||
| Partial gastrectomy | 10.71 | |||
|
| ||||
| Surgical method | 0.022 | 1 | 0.028 | |
| DPLDG | 9.42 | 0.742 (0.562, 0.982) | ||
| HALG | 13.16 | |||
|
| ||||
| Tumor length | 0.010 | 1 | 0.462 | |
| <5 cm | 9.55 | 1.137 (0.852, 1.525) | ||
| ≥5 cm | 13.42 | |||
|
| ||||
| Pathological stage | 0.003 | 1 | 0.871 | |
| Stage I | 9.06 | 1.051 (0.646, 1.751) | ||
| Stages II-III | 13.83 | |||
|
| ||||
| Intraoperative blood loss (ml) | <0.001 | 1 | <0.001 | |
| <180 ml | 16.5 | 1.635 (1.249, 2.14) | ||
| ≥180 ml | 27.4 | |||
|
| ||||
| Number of lymph nodes submitted for inspection ( | 0.633 | |||
| <25 | 11.10 | |||
| ≥25 | 11.87 | |||
|
| ||||
| Surgical time | 0.736 | |||
| Less than 180 min | 12.31 | <0.001 | ||
| No less than 180 min | 11.27 | |||
Figure 1Comparison of patients' PNI level values before surgery and at different moments after surgery between the two groups . Note. The horizontal axis indicated T0, T1, T2, and T3, and the vertical axis indicated the PNI level values. The PNI level values at T0, T1, T2, and T3 of patients in the DPLDG group were 36.26 ± 3.37, 51.26 ± 5.97, 76.63 ± 6.74, and 84.17 ± 6.69, respectively. The PNI level values at T0, T1, T2, and T3 of patients in the HALG group were 36.29 ± 3.41, 45.33 ± 5.63, 52.36 ± 6.81, and 57.26 ± 6.37, respectively. indicates that the PNI level values at T1 of patients in the two groups were significantly different (t = 14.227, p < 0.001); indicates that the PNI level values at T2 of patients in the two groups were significantly different (t = 49.861, p < 0.001); and indicates that the PNI level values at T3 of patients in the two groups were significantly different (t = 57.349, p < 0.001).
Figure 2Comparison of patients' GLQI scores before surgery and at 1 month after surgery between the two groups . Note. The horizontal axis indicated before surgery and 1 month after surgery, and the vertical axis indicated the GLQI score (points). The GLQI scores before surgery and at 1 month after surgery of patients in the DPLDG group were (92.35 ± 6.74) and (117.36 ± 5.43), respectively, and those of patients in the HALG group were (92.38 ± 6.79) and (112.36 ± 5.49), respectively. indicates that the GLQI scores before surgery and at 1 month after surgery of patients in the DPLDG group were significantly different (t = 56.771, p < 0.001); indicates that the GLQI scores before surgery and at 1 month after surgery of patients in the HALG group were significantly different (t = 45.130, p < 0.001); and indicates that the GLQI scores at 1 month after surgery of patients in the two groups were significantly different (t = 12.746, p < 0.001).